<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Antimalarials: rheumatic diseases; Mepacrine: discoid lupus erythematosus" /><meta name="IX" content="Antimalarials: rheumatic diseases; Mepacrine: discoid lupus erythematosus" /><title>Antimalarials: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="5299.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="5299.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=5299.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2077.htm">10 Musculoskeletal and joint diseases</a> &gt; <a href="5182.htm">10.1 Drugs used in rheumatic diseases and gout</a> &gt; <a href="5288.htm">10.1.3 Drugs that suppress the rheumatic disease process</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="5295.htm" title="Previous: PENICILLAMINE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="5300.htm" title="Next: CHLOROQUINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/22419-x.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mepacrine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: M &gt; Interactions of Mepacrine</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="4013.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.4.1 Antimalarials</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.4 Antiprotozoal drugs</p></div></li><li><a href="4045.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.4.4 Antigiardial drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.4 Antiprotozoal drugs</p></div></li><li><a href="4046.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">MEPACRINE HYDROCHLORIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.4 Antiprotozoal drugs &gt; 5.4.4 Antigiardial drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22antimalarials%22%22mepacrine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>BNF for Children (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/4013.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.4.1 Antimalarials</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.4 Antiprotozoal drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/5299.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimalarials</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0997.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mepacrine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; M</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/iodoquinol_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Parasitic Drugs &gt; Agents Active Against Intestinal and Intra-Abdominal Protozoa &gt; 178 Iodoquinol and Quinacrine &gt; Iodoquinol</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/iodoquinol_toxicity_and_clinical_uses_of_the_drug.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Toxicity and clinical uses of the drug</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Parasitic Drugs &gt; Agents Active Against Intestinal and Intra-Abdominal Protozoa &gt; 178 Iodoquinol and Quinacrine &gt; Iodoquinol</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/quinacrine_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Parasitic Drugs &gt; Agents Active Against Intestinal and Intra-Abdominal Protozoa &gt; 178 Iodoquinol and Quinacrine &gt; Quinacrine</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22antimalarials%22%22mepacrine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1370-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimalarials</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/1382-g.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mepacrine Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiprotozoals &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/08044.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Quinacrine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; Q &gt; QU</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E8E3E0R0D1975.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Antimalarials</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D3717.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mepacrine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; M</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_5299">Antimalarials</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i335.htm" title="Go to appendix 1">Chloroquine and Hydroxychloroquine</a>).</div><div><p>The antimalarial <b>hydroxychloroquine</b> is used to treat rheumatoid arthritis of moderate inflammatory activity; <b>chloroquine</b> is also licensed for treating inflammatory disorders
but is used much less frequently and is generally reserved for use
if other drugs have failed. Chloroquine and hydroxychloroquine are
effective for mild systemic lupus erythematosus, particularly involving
the skin and joints. These drugs should not be used for psoriatic
arthritis.</p><p><span>Chloroquine</span> and <span>hydroxychloroquine </span>are better tolerated than gold or <span>penicillamine</span>. Retinopathy (see below) rarely occurs provided that the recommended
doses are not exceeded; in the elderly it is difficult to distinguish
drug-induced retinopathy from changes of ageing.</p><p><b>Mepacrine</b> (<a title=" Antigiardial drugs" href="4045.htm#_4045">section 5.4.4</a>) is sometimes used in discoid lupus erythematosus
[unlicensed].</p><div class="cAZ" id="_5299.1"><h2>Cautions</h2> <p class="cAX"> Manufacturers recommend regular
ophthalmological examination but the evidence of practical value is
unsatisfactory (see advice of the Royal College of Ophthalmologists,
below). Chloroquine and hydroxychloroquine should be used with caution
in neurological disorders (especially in
those with a history of epilepsy), in severe gastro-intestinal disorders, in G6PD deficiency (<a title=" G6PD deficiency" href="4925.htm#_4925">section 9.1.5</a>), in acute porphyria, and in the elderly (see also above). <span>Chloroquine</span> and <span>hydroxychloroquine</span> may exacerbate psoriasis and aggravate myasthenia gravis. Concurrent
use of hepatotoxic drugs should be avoided; other <b>interactions</b>: Appendix 1 (<span>chloroquine</span> and <span>hydroxychloroquine</span>).<br /></p><div><h3 class="cAE">Screening for ocular toxicity</h3> <div id="_202153"><p><span id="_5299.2">A review group
convened by the Royal College of Ophthalmologists has updated guidelines
for screening to prevent ocular toxicity on long-term treatment with <span>chloroquine</span> and <span>hydroxychloroquine</span> (<i>Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening
2009</i>). <span>Chloroquine</span> should be considered
(for treating chronic inflammatory conditions) <b>only</b> if other drugs have failed. All patients taking <span>chloroquine</span> should receive ocular examination according
to a protocol arranged locally between the prescriber and the ophthalmologist</span>. The following recommendations relate to <span>hydroxychloroquine</span>, which is only rarely associated with
toxicity.</p><ul class="cBD"><li><p class="cQ"><i>Before treatment:</i></p></li><li><ul class="cBF"><li><p class="cQ">Assess renal and liver function (adjust dose if impaired)</p></li><li><p class="cQ">Ask patient about visual impairment (not corrected by
glasses). If impairment or eye disease present, assessment by an optometrist
is advised and any abnormality should be referred to an ophthalmologist</p></li><li><p class="cQ">Record near visual acuity of each eye (with glasses where
appropriate) using a standard reading chart</p></li><li><p class="cQ">Initiate hydroxy<span>chloroquine</span> treatment
if no abnormality detected (at a dose not exceeding <span>hydroxychloroquine </span>sulphate 6.5 mg/kg daily)</p></li></ul></li><li><p class="cQ"><i>During treatment:</i></p></li><li><ul class="cBF"><li><p class="cQ">Ask patient about visual symptoms and monitor
visual acuity annually using the standard reading chart</p></li><li><p class="cQ">Refer to ophthalmologist if visual acuity changes
or if vision blurred and warn patient to seek prescribing doctor’s
advice about stopping treatment</p></li><li><p class="cQ">A child treated for juvenile idiopathic arthritis
should receive slit-lamp examination routinely to check for uveitis</p></li><li><p class="cQ">If long-term treatment is required (more than 5 years),
individual arrangement should be agreed with the local ophthalmologist</p></li></ul></li></ul></div></div><div class="cN"><h3 class="cBP">Important</h3><p><span id="_5299.4"></span><span id="_5299.5"></span>To avoid excessive dosage in obese patients,
the doses of <span>hydroxychloroquine</span> and <span>chloroquine</span> should be calculated on the basis of ideal body-weight. Ocular toxicity is unlikely if the dose of <span>chloroquine</span> phosphate does not exceed 4 mg/kg daily (equivalent to <span>chloroquine</span> base approx. 2.5 mg/kg daily)</p></div></div><div id="_204142"><div class="cAZ"><h2>Hepatic impairment</h2> <p class="cAX"><span>Chloroquine</span> and <span>hydroxychloroquine</span> should be used with caution
in moderate to severe hepatic impairment.</p></div></div><div id="_204143"><div class="cAZ"><h2>Pregnancy</h2> <p class="cAX">It is not necessary to withdraw an antimalarial
drug during pregnancy if the rheumatic
disease is well controlled; however, the manufacturer of hydroxychloroquine
advises avoiding use.</p></div></div><div id="_207428"><div class="cAZ"><h2>Breast-feeding</h2> <p class="cAX"><span>Chloroquine</span> and <span>hydroxychloroquine</span> are present in breast milk and breast-feeding should be avoided when they
are used to treat rheumatic disease.</p></div></div><div id="_202232"><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">The side-effects of <span>chloroquine</span> and <span>hydroxychloroquine</span> include gastro-intestinal
disturbances, headache and skin reactions (rashes, pruritus); those
occurring less frequently include ECG changes, convulsions, visual
changes, retinal damage (see above), keratopathy, ototoxicity, hair
depigmentation, hair loss, and discoloration of skin, nails, and mucous
membranes. Side-effects that occur rarely include blood disorders
(including thrombocytopenia, agranulocytosis, and aplastic anaemia),
mental changes (including emotional disturbances and psychosis), myopathy
(including cardiomyopathy and neuromyopathy), acute generalised exanthematous
pustulosis, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity,
and hepatic damage; angioedema has also been reported. <b>Important</b>: very toxic in overdosage—immediate advice from poisons centres
essential (see also <a title="monograph-family: Antimalarials" href="29540.htm#_29540">Emergency Treatment of Poisoning</a>).</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_5300"><a href="5300.htm" title="CHLOROQUINE">CHLOROQUINE</a></li><li id="_5302"><a href="5302.htm" title="HYDROXYCHLOROQUINE SULPHATE">HYDROXYCHLOROQUINE SULPHATE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="5295.htm">Previous: PENICILLAMINE</a> | <a class="top" href="5299.htm#">Top</a> | <a accesskey="]" href="5300.htm">Next: CHLOROQUINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>